Similar articles

• Translational research on the clinical applications of ghrelin.

  Akamizu T, Kangawa K. Akamizu T, et al. Endocr J. 2006 Oct;53(5):585-91. doi: 10.1507/endocrj.kr-79. Epub 2006 Jul 28. Endocr J. 2006. PMID: 16873986 Review. No abstract available.
• [Translational research of ghrelin in endocrine and metabolic diseases].

  Akamizu T, Irako T, Hosoda H, Takaya K, Kangawa K. Akamizu T, et al. Nihon Rinsho. 2004 Sep;62 Suppl 9:424-9. Nihon Rinsho. 2004. PMID: 15506420 Review. Japanese. No abstract available.
• Nonpeptide and peptide growth hormone secretagogues act both as ghrelin receptor agonist and as positive or negative allosteric modulators of ghrelin signaling.

  Holst B, Brandt E, Bach A, Heding A, Schwartz TW. Holst B, et al. Mol Endocrinol. 2005 Sep;19(9):2400-11. doi: 10.1210/me.2005-0059. Epub 2005 May 19. Mol Endocrinol. 2005. PMID: 15905359
• Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart.

  Frascarelli S, Ghelardoni S, Ronca-Testoni S, Zucchi R. Frascarelli S, et al. Basic Res Cardiol. 2003 Nov;98(6):401-5. doi: 10.1007/s00395-003-0434-7. Epub 2003 Aug 21. Basic Res Cardiol. 2003. PMID: 14556085
• Effect of ghrelin and growth hormone-releasing peptide 6 on septic ileus in mice.

  De Winter BY, De Man JG, Seerden TC, Depoortere I, Herman AG, Peeters TL, Pelckmans PA. De Winter BY, et al. Neurogastroenterol Motil. 2004 Aug;16(4):439-46. doi: 10.1111/j.1365-2982.2004.00564.x. Neurogastroenterol Motil. 2004. PMID: 15305999